Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Tevogen Bio Holdings Inc (TVGN)

Tevogen Bio Holdings Inc (TVGN)
1.0000 x 9 1.0200 x 12
Post-market by (Cboe BZX)
1.0200 +0.0500 (+5.15%) 04/23/25 [NASDAQ]
1.0000 x 9 1.0200 x 12
Post-market 1.0200 unch (unch) 16:21 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.9600
Day High
1.0300
Open 0.9600
Previous Close 0.9700 0.9700
Volume 320,585 320,585
Avg Vol 511,679 511,679
Stochastic %K 23.36% 23.36%
Weighted Alpha -70.58 -70.58
5-Day Change -0.0300 (-2.86%) -0.0300 (-2.86%)
52-Week Range 0.2556 - 3.0900 0.2556 - 3.0900
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 178,376
  • Shares Outstanding, K 183,893
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,730 K
  • EBIT $ -54 M
  • EBITDA $ -53 M
  • 60-Month Beta -0.84
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8900 +14.61%
on 04/04/25
Period Open: 1.1400
1.2600 -19.05%
on 03/26/25
-0.1200 (-10.53%)
since 03/21/25
3-Month
0.8900 +14.61%
on 04/04/25
Period Open: 1.3800
1.9200 -46.88%
on 01/27/25
-0.3600 (-26.09%)
since 01/23/25
52-Week
0.2556 +299.06%
on 10/09/24
Period Open: 1.6500
3.0900 -66.99%
on 10/25/24
-0.6300 (-38.18%)
since 04/23/24

Most Recent Stories

More News
Tevogen Bio Finalizes Agreement for Company’s Own Cell Therapy Production Facility

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market

/CNW/ -- Equity Insider News Commentary – The potential for artificial intelligence (AI) in healthcare is still unfolding, both for patients and providers. A...

AVAI : 0.3603 (-2.62%)
AMST : 2.06 (-1.44%)
BTAI : 1.6900 (+0.60%)
TVGN : 1.0200 (+5.15%)
PLTR : 100.82 (+7.27%)
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure

TVGNW : 0.0478 (+11.42%)
TVGN : 1.0200 (+5.15%)

Business Summary

Semper Paratus entered in definitive agreement for a business combination with Tevogen Bio Inc.

See More

Key Turning Points

3rd Resistance Point 1.0433
2nd Resistance Point 1.0167
1st Resistance Point 0.9933
Last Price 1.0200
1st Support Level 0.9433
2nd Support Level 0.9167
3rd Support Level 0.8933

See More

52-Week High 3.0900
Fibonacci 61.8% 2.0073
Fibonacci 50% 1.6728
Fibonacci 38.2% 1.3383
Last Price 1.0200
52-Week Low 0.2556

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective